Table 2. Characteristics of 680 health facilities, and circumstances of microscopy and malaria RDT use.
| Health post | Health centre | Reference health centre | Hospital | Laboratory and supervising | Total | |
| Number | 80 | 429 | 90 | 70 | 11 | 680 |
| Microscopy | ||||||
| No reply | 2.5% | 3.3% | 1.1% | 0.0% | 0.0% | 2.5% |
| No | 56.3% | 45.0% | 10.0% | 2.9% | 9.1% | 36.8% |
| Yes | 41.3% | 51.7% | 88.9% | 97.1% | 90.9% | 60.7% |
| Always | 13.8% | 22.6% | 58.9% | 61.4% | 72.7% | 31.2% |
| RDT stock out | 13.8% | 11.0% | 3.3% | 2.9% | 9.1% | 9.4% |
| Malaria suspicion with negative RDT | 7.5% | 8.6% | 7.8% | 2.9% | 0.0% | 7.6% |
| Request from clinician | 3.8% | 4.0% | 12.2% | 24.3% | 0.0% | 7.1% |
| Other or not specifieda | 2.5% | 5.6% | 6.7% | 5.7% | 9.1% | 5.4% |
| RDT use | ||||||
| No reply | 0.0% | 2.1% | 0.0% | 0.0% | 0.0% | 1.3% |
| No | 2.5% | 14.0% | 18.9% | 15.7% | 36.4% | 13.8% |
| Yes | 97.5% | 83.9% | 81.1% | 84.3% | 63.6% | 84.9% |
| Always | 78.8% | 52.9% | 42.2% | 27.1% | 27.3% | 51.5% |
| Request from clinician | 5.0% | 4.2% | 11.1% | 35.7% | 9.1% | 8.5% |
| Giemsa stock out or no microscope | 3.8% | 6.5% | 7.8% | 4.3% | 9.1% | 6.2% |
| If RDT availableb | 5.0% | 6.5% | 5.6% | 4.3% | 9.1% | 6.0% |
| RDT in ward, microscopy in lab | 2.5% | 4.7% | 4.4% | 5.7% | 0.0% | 4.4% |
| Malaria suspicion with negative TBF | 0.0% | 3.3% | 5.6% | 4.3% | 0.0% | 3.2% |
| Other or not specified | 2.5% | 5.8% | 4.4% | 2.9% | 9.1% | 5.0% |
| Training | ||||||
| No reply | 0.0% | 4.0% | 3.3% | 2.9% | 0.0% | 3.2% |
| No | 70.0% | 39.2% | 50.0% | 38.6% | 72.7% | 44.7% |
| Yes | 30.0% | 56.9% | 46.7% | 58.6% | 27.3% | 52.1% |
| Consultations/month, median (IQR)c | 25 (18–33) | 130 (56–308) | 201 (86–338) | 304 (157–711) | 40 (26–50) | 30 (8–80) |
| RDT/month, median (IQR)c | 11 (5–22) | 40 (13–90) | 40 (13–106) | 50 (6–114) | 97 (30–112) | 35 (11–88) |
TBF Thick blood film; RDT rapid diagnostic test.
a
besides facilities not specifying the circumstances of use, includes the options: (i) RDT in ward, microscopy in laboratory; (ii) patient follow-up; (iii) person performing the RDT absent; (iv) other.
b
under the option “other”, 41/47 health facilities indicated themselves to perform RDTs if they were available.
c
in April 2012.